COPD Prognosis in Covid Patients
Chronic Obstructive Pulmonary Disease Prognosis in Sars-covid 2 Infection
1 other identifier
observational
100
1 country
1
Brief Summary
In this prospective observational study, patients were selected from attendees of the intensive care unit. Different measures and outcomes had been studied and compared between patients with and without COPD, including hospitalization, medical costs, length of Intensive care stay, respiratory failure, and death rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 5, 2022
CompletedFirst Posted
Study publicly available on registry
March 10, 2022
CompletedMarch 10, 2022
March 1, 2022
6 months
March 5, 2022
March 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SOFA score measurement in both groups
monitoring of SOFA items along two weeks
2 weeks
Secondary Outcomes (1)
prognosis of the disease
2 weeks
Study Arms (2)
copd patients with covid infection
non-copd patients with covid infection
Interventions
patients who were in need were intubated and mechanically ventilated
Eligibility Criteria
male or female patient more than 20 years old, recently diagnosed covid positive
You may qualify if:
- Age: more than 20 years old.
- Both Males and females will be included.
- COPD patients.
- Recent confirmed the diagnosis with SARS-COV-2.
You may not qualify if:
- Pregnancy.
- Malignancy.
- Immunodeficiency disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Faculty of Medicine, Sohag University
Sohag, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia and intensive care
Study Record Dates
First Submitted
March 5, 2022
First Posted
March 10, 2022
Study Start
June 1, 2021
Primary Completion
December 1, 2021
Study Completion
January 1, 2022
Last Updated
March 10, 2022
Record last verified: 2022-03